SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
LNTH
--
0.00%
--
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.
PR Newswire · 05/28 00:53
Healthcare And Biotechnology Dashboard - Update
Seeking Alpha - Article · 05/26 23:03
Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference
Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced Ma
Business Wire · 05/20 20:30
Lantheus (LNTH) Presents At UBS Global Healthcare Conference - Slideshow
Seeking Alpha - Article · 05/20 19:56
Lantheus Holdings to Present at the UBS Virtual Global Healthcare Conference
Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced Ma
Business Wire · 05/05 20:30
Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/02 09:08
Edited Transcript of LNTH earnings conference call or presentation 30-Apr-20 12:00pm GMT
Thomson Reuters StreetEvents · 04/30 23:27
Lantheus Holdings Inc (LNTH) Q1 2020 Earnings Call Transcript
Image source: The Motley Fool. Lantheus Holdings Inc (NASDAQ: LNTH)Q1 2020 Earnings CallApr 30, 2020, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning, ladies and gentlemen.
Motley Fool · 04/30 22:30
Lantheus Holdings, Inc. Reports First Quarter 2020 Financial Results
Business Wire · 04/30 12:00
Recap: Lantheus Holdings Q1 Earnings
Shares of Lantheus Holdings (NASDAQ:LNTH) remained unaffected at $14.03 after the company reported Q1 results. Quarterly Results Earnings per share rose 28.57% over the past year to $0.36, which beat the estimate of $0.27.
Benzinga · 04/30 11:39
Recap: Lantheus Holdings Q1 Earnings
Shares of Lantheus Holdings (NASDAQ:LNTH) remained unaffected at $14.03 after the company reported Q1 results.Quarterly Results Earnings per share rose 28.57% over the past year to $0.36, which beat the estimate of $0.27.Revenue of $90,704,000 rose by 4.85% ye
Benzinga · 04/30 11:39
Lantheus Holdings Q1 Adj. EPS $0.360 Beats $0.270 Estimate, Sales $90.700M Miss $91.200M Estimate
Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $0.360 per share which beat the analyst consensus estimate of $0.270 by 33.33 percent. This is a 28.57 percent increase over earnings of $0.280 per share
Benzinga · 04/30 11:15
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market.
Benzinga · 04/26 20:37
Healthcare And Biotechnology Dashboard - Update
Seeking Alpha - Article · 04/20 19:34
Lantheus Holdings to Host First Quarter 2020 Earnings Conference Call on April 30, 2020 at 8:00 a.m. Eastern Time
Business Wire · 04/16 12:30
ADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and Progenics
Business Wire · 04/14 16:17
Lantheus, Progenics Pharma Report Support Deal With Velan Capital Related To Merger
Benzinga · 04/14 13:21
Lantheus Holdings, Inc. Reports Preliminary Q1 Revenue Near Top End of Previously Disclosed Guidance Range; Withdraws 2020 Financial Guidance
Business Wire · 04/09 13:30
Lantheus Sees Q1 Sales Near High End Of Previously-Issued Range; Withdraws FY20 Guidance
Benzinga · 04/09 12:36
Lantheus Holdings Sees Prelim. Q1 Sales Near Top End Of Guidance Range, Withdraws 2020 Guidance
Benzinga · 04/09 12:32